Back to search
High Risk Locally Advanced Nasopharyngeal Carcinoma
Clinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Locally Advanced Nasopharyngeal Carcinoma trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which High Risk Locally Advanced Nasopharyngeal Carcinoma trials you may qualify forIn this study, the investigators designed a randomized, open-label, phase II clinical trial for high-risk locally advanced nasopharyngeal carcinoma (T4 or N3 or…
Based on the short-term efficacy and plasma EBV DNA levels following immuno-induction chemotherapy, patients with locally advanced nasopharyngeal carcinoma who…
This is an open label, multicenter, phase 1/2 study to assess the safety/tolerability and preliminary clinical activity of STAR0602 as a single agent administer…
In order to explore the efficacy and safety of targeted therapy and immunotherapy combined with GP chemotherapy in the treatment of high risk advanced nasophary…
This is a randomized,controlled,prospective phase III clinical trial. The purpose of this study is to evaluate acute toxicity and efficacy of concurrent cisplat…
Nearly half of the world's nasopharyngeal cancer occurs in China, among which the highest incidence in Guangdong and Guangxi, so the nickname "Guangdong tumor".…